News Novimmune files rare disease drug in EU, after selling right... Deal could be worth more than $450 million
News A gamechanger in haemophilia? SOBI unruffled by Roche's impe... The received wisdom is that a generation of new products in haemophilia A, led by Roche’s emicizumab and potentially curative gene therapies, will bring about a transformation of treatment
News New haemophilia drug Elocta approved in Europe Elocta, a new drug co-marketed by Sobi and Biogen, has been approved in the European Union.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
